23 results match your criteria: "Centre d'Etudes des Pathologies Respiratoires[Affiliation]"
Ann Intensive Care
September 2024
Service de Médecine Intensive Réanimation, CHRU Tours, Tours, France.
Background: Activation of innate immunity is a first line of host defense during acute critical illness (ACI) that aims to contain injury and avoid tissue damages. Aberrant activation of innate immunity may also participate in the occurrence of organ failures during critical illness. This review aims to provide a narrative overview of recent advances in the field of innate immunity in critical illness, and to consider future potential therapeutic strategies.
View Article and Find Full Text PDFEur J Med Chem
November 2024
EA 7502 Synthèse et Isolement de Molécules Bioactives (SIMBA), University of Tours, France. Electronic address:
Ann Intensive Care
June 2024
Service de Réanimation Médico-Chirurgicale, CH Le Mans, Le Mans, France.
Background: The COVID-19 pandemic has highlighted the importance of intensive care units (ICUs) and their organization in healthcare systems. However, ICU capacity and availability are ongoing concerns beyond the pandemic, particularly due to an aging population and increasing complexity of care. This study aimed to assess the current and future shortage of ICU physicians in France, ten years after a previous evaluation.
View Article and Find Full Text PDFJ Clin Med
May 2024
Service de Médecine Interne et Immunologie Clinique, Centre de Compétence Maladies Systémiques Auto-Immunes Rares, CHRU Tours, 37000 Tours, France.
High-resolution computed tomography (HRCT) may lack sensitivity for the early detection of interstitial lung disease associated with systemic sclerosis (SSc-ILD). Lung ultrasound is an emerging technique for the diagnosis of SSc-ILD. This cross-sectional study aimed to describe the prevalence of ultrasound interstitial syndrome in SSc patients with normal HRCT and pulmonary function tests (PFT).
View Article and Find Full Text PDFAnn Intensive Care
July 2023
Medical Intensive Care Unit, GHRMSA, Mulhouse, France.
Introduction: New beta-lactams, associated or not with beta-lactamase inhibitors (NBs/BIs), can respond to the spread of carbapenemase-producing enterobacteriales and nonfermenting carbapenem-resistant bacteria. The risk of emergence of resistance to these NBs/BIs makes guidelines necessary. The SRLF organized a consensus conference in December 2022.
View Article and Find Full Text PDFAnn Intensive Care
April 2023
Service de Médecine Intensive - Réanimation, Hôpital Tenon, Groupe hospitalo-universitaire Assistance Publique - Hôpitaux de Paris, Sorbonne Université (GHU AP-HP Sorbonne Université), Paris, France.
Over the past 2 years, SARS-CoV-2 infection has resulted in numerous hospitalizations and deaths worldwide. As young intensivists, we have been at the forefront of the fight against the COVID-19 pandemic and it has been an intense learning experience affecting all aspects of our specialty. Critical care was put forward as a priority and managed to adapt to the influx of patients and the growing demand for beds, financial and material resources, thereby highlighting its flexibility and central role in the healthcare system.
View Article and Find Full Text PDFAnn Intensive Care
July 2022
Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, 94143, USA.
Br J Pharmacol
January 2022
Centre d'Etudes des Pathologies Respiratoires, Inserm UMR1100, Tours, France.
Background And Purpose: The Arp2/3 multiprotein complex regulates branched polymerisation of the actin cytoskeleton and may contribute to collagen synthesis and fibrogenesis in the lung.
Experimental Approach: Expression of Arp2/3 components was assessed in human lung fibroblasts and in the bleomycin-induced pulmonary fibrosis model in mice. The Arp2/3 complex was repressed with the allosteric inhibitor CK666 and with interfering RNAs targeting the ARP2, ARP3 and ARPC2 subunits (siARP2, siARP3 and siARPC2) in CCD-16Lu human lung fibroblasts in vitro.
Ann Intensive Care
July 2021
Médecine Intensive Réanimation, CHU de Poitiers, Poitiers, France.
Background: Critically ill patients with obesity may have an increased risk of difficult intubation and subsequent severe hypoxemia. We hypothesized that pre-oxygenation with noninvasive ventilation before intubation as compared with high-flow nasal cannula oxygen may decrease the risk of severe hypoxemia in patients with obesity.
Methods: Post hoc subgroup analysis of critically ill patients with obesity (body mass index ≥ 30 kg·m) from a multicenter randomized controlled trial comparing preoxygenation with noninvasive ventilation and high-flow nasal oxygen before intubation of patients with acute hypoxemic respiratory failure (PaO/FiO < 300 mm Hg).
Ann Intensive Care
July 2021
Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum, Ulm, Germany.
Ann Intensive Care
November 2019
Service de Médecine Intensive Réanimation, CHRU de Tours, 2 Bd Tonnellé, 37044, Tours Cedex 9, France.
J Cyst Fibros
May 2020
Inserm U1070, Poitiers, France; Université de Poitiers, UFR Médecine-Pharmacie, Poitiers, France.
Objectives: Colistin, administered as the prodrug colistin methanesulphonate (CMS), is an antibiotic frequently administered as aerosol in cystic fibrosis (CF) patient. Our aim was to assess the plasma PK of colistin in CF patients treated with CMS administered intravenously or as aerosol and to compare these results with those previously reported in healthy volunteers.
Methods: Six CF patients were included, CMS and colistin concentrations were measured in plasma, urine and sputum.
J Aerosol Med Pulm Drug Deliv
December 2019
Centre d'études des pathologies respiratoires, INSERM U1100, Faculté de médecine, Université de Tours, Tours, France.
The use of nasal high-flow (NHF) therapy is rapidly spreading across acute care facilities. This raises the question of optimal delivery of inhaled medication to patients undergoing this noninvasive ventilatory support consisting in delivering heated and humidified high gas flow rates through nasal cannulas. In this article, we review experimental and clinical work evaluating the delivery of inhaled medication within the NHF circuit to target the lung without interrupting the ventilatory support.
View Article and Find Full Text PDFLancet Respir Med
April 2019
CHU de Poitiers, Médecine Intensive Réanimation, Poitiers, France; équipe 5 ALIVE, INSERM, CIC-1402, Poitiers, France; Faculté de Médecine et de Pharmacie de Poitiers, Université de Poitiers, Poitiers, France.
Background: Non-invasive ventilation has never been compared with high-flow oxygen to determine whether it reduces the risk of severe hypoxaemia during intubation. We aimed to determine if preoxygenation with non-invasive ventilation was more efficient than high-flow oxygen in reducing the risk of severe hypoxaemia during intubation.
Methods: The FLORALI-2 multicentre, open-label trial was done in 28 intensive care units in France.
Mol Immunol
September 2019
Institut National de la Sante et de la Recherche Médicale, Unité 1151; Université Paris Descartes, Faculté de médecine; Centre National de la Recherche Scientifique, UMR8253; 149 rue de Sèvres, 75743 Paris Cedex 15, France. Electronic address:
Cross-presentation is thought to require transport of proteasome-generated peptides by the TAP transporters into MHC class I loading compartments for most antigens. However, a proteasome-dependent but TAP-independent pathway has also been described. Depletion of the pool of recycling cell surface MHC class I molecules available for loading with cross-presented peptides might partly or largely account for the critical role of TAP in cross-presentation of phagocytosed antigens.
View Article and Find Full Text PDFRev Pneumol Clin
February 2018
Service de pneumologie et explorations fonctionnelles respiratoires, CHU de Tours, 37032 Tours, France; Inserm U-1100/EA-6305, centre d'études des pathologies respiratoires, faculté de médicine François-Rabelais, 37032 Tours, France. Electronic address:
Introduction: The pentoxifylline seems to have some effects on immune cells by inhibiting tumor necrosis factor alpha (TNFα). Its role as a sparing corticosteroids in the treatment of sarcoidosis remains to be defined.
Clinical Case: We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine.
J Infect Dis
July 2016
Institut National de la Santé et de la Recherche Médicale (INSERM), UMR_S 1062 INRA, UMR_INRA 1260, France Aix Marseille Université
Background: The pathogenesis of influenza A virus (IAV) infections is a multifactorial process that includes the replication capacity of the virus and a harmful inflammatory response to infection. Formyl peptide receptor 2 (FPR2) emerges as a central receptor in inflammatory processes controlling resolution of acute inflammation. Its role in virus pathogenesis has not been investigated yet.
View Article and Find Full Text PDFInt J Pharm
August 2014
Université Claude Bernard Lyon 1, Laboratoire d'Automatique et de Génie des Procédés (LAGEP), UMR-CNRS 5007, CPE Lyon, Bât 308 G, 43 Boulevard du 11 Novembre 1918, Villeurbanne Cedex F-69622, France. Electronic address:
The targeted release of drugs intended for pulmonary delivery is a research field which has been so far rather unexploited but is currently becoming increasingly attractive. Liquid dispersions encapsulating vitamin E (liposomes, micelles, nano-emulsion, and solid lipid particles) were prepared using various methods based on membrane contactor. The dispersions were nebulized and aerodynamic characteristics of the generated aerosols were assessed using two different methods: laser light scattering and cascade impaction.
View Article and Find Full Text PDFInt J Pharm
February 2014
Université Jean Monnet, LINA EA 4624, Université de Lyon, F-42023 Saint-Etienne, France; SFR IFRESIS, F-42023 Saint-Etienne, France; Centre Hospitalier Emile Roux, ENT Department, F-43012 Le Puy en Velay, France.
Purpose: Aerosol inhalation therapy is one of the methods to treat rhinosinusitis. However the topical drug delivery to the posterior nose and paranasal sinuses shows only limited efficiency. A precise sinusal targeting remains a main challenge for aerosol treatment of sinus disorders.
View Article and Find Full Text PDFPLoS One
July 2014
DTF Aerodrug, Faculté de Médecine, Université François Rabelais, Tours, France ; Centre d'Etudes des Pathologies Respiratoires INSERM U1100/EA 6305, Faculté de Médecine, Université François Rabelais, Tours, France.
The development of jet nebulizers for medical purposes is an important challenge of aerosol therapy. The performance of a nebulizer is characterized by its output rate of droplets with a diameter under 5 µm. However the optimization of this parameter through experiments has reached a plateau.
View Article and Find Full Text PDFInt Immunopharmacol
December 2013
"Centre d'Etudes des Pathologies Respiratoires", INSERM U-1100/EA-6305 37032, Université François Rabelais, 37032 Tours, France. Electronic address:
Proteinase 3 (PR3) is one of the four elastase-related serine proteinases stored in the azurophilic granules of neutrophils. Although it participates in the pro- and anti-inflammatory responses to infection and inflammation it also retains specific functions that make it different from neutrophil elastase in spite of their close structural resemblance. PR3 is involved in the immune response to infection and is the major autoantigen in granulomatosis with polyangiitis (GPA, formerly Wegener disease), an autoimmune systemic vasculitis with granulomas.
View Article and Find Full Text PDFCurr Pharm Des
July 2013
INSERM U-1100/EA-6305 Centre d'Etudes des Pathologies Respiratoires, Université François Rabelais, Faculté de Médecine, 37032, Tours, France.
Human neutrophil proteinase 3 (PR3) and elastase (HNE) are homologous serine proteinases involved in the proteolytic events associated with inflammation and infection. Their close structural and functional resemblance makes it difficult to understand their respective biological functions. Thus, all natural inhibitors of PR3 identified to date preferentially target HNE, and only recently have inhibitors that target PR3 selectively been described.
View Article and Find Full Text PDF